Golden G S
Child Development Center; University of Tennessee Center for the Health Sciences, Memphis 38105.
Pediatr Neurol. 1985 May-Jun;1(3):192-4. doi: 10.1016/0887-8994(85)90063-3.
Three patients are reported who developed oral-buccal-lingual movements typical of tardive dyskinesia while being treated with stable doses of haloperidol for Tourette syndrome. In each case signs resolved within a number of weeks after medication was discontinued. One of the patients experienced recurrence of the dyskinesia during a challenge with phenothiazine tranquilizers. In each case the dose of haloperidol was well within the usual therapeutic range. A strong family history of movement disorders, including Tourette syndrome, was present in each family.
报告了3例患有图雷特综合征的患者,他们在使用稳定剂量的氟哌啶醇治疗期间出现了迟发性运动障碍典型的口腔 - 颊 - 舌运动。在每例患者中,停药后数周内症状均得到缓解。其中1例患者在使用吩噻嗪类镇静剂激发试验期间迟发性运动障碍复发。在每例患者中,氟哌啶醇的剂量均在通常的治疗范围内。每个家庭都有包括图雷特综合征在内的运动障碍的强烈家族病史。